The Cancer Center at NIT is a Basic Cancer Center comprising three integrated research programs involving more than two dozen laboratories at NIT. Most laboratories are located in three buildings of the Biology Department (Cancer Center, Biology building, Whitehead Institute) and share many common research facilities. Research programs focus on the underlying cell and molecular biology of cell behavior with particular emphasis on issues related to cancer; control of cell proliferation, cell cycle and cell survival, gene expression, cell adhesion and migration, tumor progression, angiogenesis and metastasis. There is a strong emphasis on the use of genetics and molecular genetics to discover genes controlling these processes and/or altered in cancer using human genomics and genetic studies in model organisms (mice, zebrafish, invertebrates and yeast). Three programs in Molecular Genetics & Immunology, Tumor Suppressors, Cell Cycle & Checkpoints, and Cell Biology, Development & Differentiation unite the center members; each is headed by a leader in the field. The major budget requests are to fund shared facilities (Biopolymers, Cell Sorter, Computing Glassware, Histology, Media Preparation, Microarray Technologies, Microscopy, Monoclonal Antibodies, Shared Research Resources, Transgenic Mouse Facility) and infrastructure that support and enhance the scientific research of the center and for developmental funds to foster new directions and initiatives in cancer research. No funds are requested for senior leadership or staff investigator salaries.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014051-29
Application #
6091308
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1975-09-01
Project End
2005-04-30
Budget Start
2000-07-26
Budget End
2001-04-30
Support Year
29
Fiscal Year
2000
Total Cost
$2,336,099
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Organized Research Units
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Gam, Jeremy J; Babb, Jonathan; Weiss, Ron (2018) A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity. Nat Commun 9:2430
Chen, Huihui; Cho, Kin-Sang; Vu, T H Khanh et al. (2018) Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun 9:3209
Tam, Brooke E; Hao, Yining; Sikes, Hadley D (2018) An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 34:1589-1595
Ramadi, Khalil B; Dagdeviren, Canan; Spencer, Kevin C et al. (2018) Focal, remote-controlled, chronic chemical modulation of brain microstructures. Proc Natl Acad Sci U S A 115:7254-7259
Knouse, Kristin A; Lopez, Kristina E; Bachofner, Marc et al. (2018) Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell 175:200-211.e13
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Clancy-Thompson, Eleanor; Devlin, Christine A; Tyler, Paul M et al. (2018) Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer Immunol Res 6:1524-1536
Fiedler, Eleanor R C; Bhutkar, Arjun; Lawler, Emily et al. (2018) In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL. Blood Adv 2:1229-1242

Showing the most recent 10 out of 904 publications